Diferencia entre revisiones de «Tinea capitis»
(Text replacement - "==Diagnosis==" to "==Evaluation==") |
(Add peer-reviewed reference) |
||
| (No se muestran 4 ediciones intermedias de 3 usuarios) | |||
| Línea 1: | Línea 1: | ||
==Background== | ==Background== | ||
*Infection caused by dermatophytes that feed on keratin | *Infection caused by dermatophytes that feed on keratin<ref>Fuller LC, et al. British Association of Dermatologists guidelines for the management of tinea capitis 2014. Br J Dermatol. 2014;171(3):454-463. PMID 25234064</ref> | ||
{{Tinea types}} | {{Tinea types}} | ||
==Clinical Features== | ==Clinical Features== | ||
[[File:Teigne tondante enfant.jpg|thumb|Tinea capitis]] | |||
[[File:TineaCapit-001.jpg|thumb|Tinea Capitis]] | [[File:TineaCapit-001.jpg|thumb|Tinea Capitis]] | ||
*Scaly, variable pruritus | *[[Rash|Scaly]], variable [[pruritus]] | ||
*Patchy alopecia | *Patchy [[alopecia]] | ||
==Differential Diagnosis== | ==Differential Diagnosis== | ||
| Línea 13: | Línea 14: | ||
==Evaluation== | ==Evaluation== | ||
*Clinical diagnosis | *Clinical diagnosis | ||
*Can be complicated by development of [[kerion]] | |||
==Management== | ==Management== | ||
| Línea 28: | Línea 30: | ||
[[Category:Dermatology]] | [[Category:Dermatology]] | ||
[[Category:Pediatrics]] | [[Category:Pediatrics]] | ||
[[Category:ID]] | |||
Revisión actual - 10:19 22 mar 2026
Background
- Infection caused by dermatophytes that feed on keratin[1]
Tinea Types
- Tinea capitis (head)
- Tinea corporis (body)
- Tinea pedis (foot)
- Tinea cruris (groin)
Clinical Features
Differential Diagnosis
Neonatal Rashes
- Acne
- Atopic dermatitis
- Candidiasis
- Contact dermatitis
- Diaper dermatitis
- Erythema toxicum neonatorum
- Impetigo
- Mastitis
- Milia
- Miliaria
- Mongolian spots
- Omphalitis
- Perianal streptococcal dermatitis
- Psoriasis
- Pustular melanosis
- Seborrheic dermatitis
- Sucking blisters
- Tinea capitis
Evaluation
- Clinical diagnosis
- Can be complicated by development of kerion
Management
- Treatment involves oral antifungal with topical antifungals not effective due to inadequate penetration of hair follicles and may miss sites of subclinical infection
- Griseofulvin Microsize: 20-25 mg/kg/day (max 1000mg) x 6-12 weeks; Ultramicrosize: 10-15 mg/kg/day (max 750mg) x 6-12 weeks (first line)
- No labs needed before griseofulvin treatment. However if repeat courses or if therapy continued beyond 8 weeks then obtain CBC and LFTs.
- Give with fatty food (like peanut butter, ice cream) for better absorption. Therapy can fail due to lack of absorption.
- Terbinafine 10-20kg: 62.5mg daily; 20-40kg: 125mg daily; >40kg: 250mg daily x 4-6 weeks is alternative first line however need LFTs prior to therapy (can be taken without regard to meals)
- Second line (both below with limited efficacy data):
- Fluconazole 6mg/kg PO daily (max 400mg) x 3-6 weeks
- Itraconazole 3-5mg/kg PO daily (max 400mg) x 4-6 weeks
- Adjunctive interventions
- Selenium sulfide 1 or 2.5%, ciclopirox 1%, or ketoconazole 2% shampoo at least twice weekly to decrease shedding of fungal spores
- Use of antifungal shampoo by other household members may also decrease the risk for reinfection
- Combs and hair trimming equipment be cleaned mechanically and disinfected (eg, with household bleach)
Disposition
- Discharge
See Also
References
- ↑ Fuller LC, et al. British Association of Dermatologists guidelines for the management of tinea capitis 2014. Br J Dermatol. 2014;171(3):454-463. PMID 25234064